Quality & complianceOfficial
Denmark flags supply problems for Fresenius Kabi ceftazidime 1000 mg injection powder
🇩🇰 DKMA · Mon 16 Nov 2026
The Danish Medicines Agency lists Ceftazidim "Fresenius Kabi" 1000 mg as having supply difficulties from November 2026, citing commercial reasons, with no end date known.
The Danish Medicines Agency (DKMA) has published a supply notice for Ceftazidim "Fresenius Kabi" 1000 mg powder for solution for injection, marketed by Fresenius Kabi AB. The notice is dated 16 November 2026 and states that there are current problems with supply of the product.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
Already a subscriber? Enter your email below: we'll send you a sign-in link. No password needed.
Article written by VigiEye from the official source (DKMA). AI-assisted; check the source before acting.
More Quality & compliance
All →
USFDA closes Dr. Reddy's Bachupally FTO-3 inspection with Voluntary Action Indicated status
Dr Reddys Laboratories Ltd (RDY) · Mon 16 Nov 2026
BfArM lists urgent field safety notice for ICU Medical's TEGO hemodialysis connector
🇩🇪 BfArM field safety notices · Mon 16 Nov 2026
Florida man pleads guilty to $42M Medicare fraud involving DME and cancer genetic tests
🇺🇸 HHS OIG · Mon 16 Nov 2026
Denmark flags supply problems for Fresenius Kabi ceftazidime 2000 mg injection
🇩🇰 DKMA · Mon 16 Nov 2026
Greek regulator EOF orders market recall of non-sterile zig-zag cotton gauze roll
🇬🇷 EOF · Mon 16 Nov 2026
Spain's major-impact medicine supply problems drop below 0.20% for first time in five years
🇪🇸 AEMPS · Mon 16 Nov 2026